Armephaco JSC

Armephaco JSC Accounts Payable

The Accounts Payable of Armephaco JSC (AMP.VN) as of Nov 5, 2026 is 417.96 B VND. In the previous year, Accounts Payable was 301.73 B VND — a change of 38.52% (higher).

Accounts Payable

417.96 BVND

YoY

38.52%

Last updated:

Accounts Payable of Armephaco JSC is 2025 417.96 B VND. Accounts Payable of Armephaco JSC was 2024 301.73 B VND. It decreases by 38.52% higher compared to the previous year.

The Armephaco JSC Accounts Payable history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Accounts Payable
Date
Accounts Payable
Jan 1, 2018
263.88 B VND
Jan 1, 2019
193.48 B VND
Jan 1, 2020
124.35 B VND
Jan 1, 2021
251.83 B VND
Jan 1, 2022
259.65 B VND
Jan 1, 2023
289.41 B VND
Jan 1, 2024
301.73 B VND
Jan 1, 2025
417.96 B VND
The Armephaco JSC Accounts Payable history
YEARAccounts PayableYoY
417.96 BVND+38.52%
301.73 BVND+4.25%
289.41 BVND+11.46%
259.65 BVND+3.11%
251.83 BVND+102.51%
124.35 BVND-35.73%
193.48 BVND-26.68%
263.88 BVND+41.91%
185.94 BVND+0.76%
184.53 BVND-7.91%
200.38 BVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Armephaco JSC Stock analysis

What does Armephaco JSC do? Armephaco JSC manufactures pharmaceutical and medical equipment products, focusing on glucose meters, sphygmomanometers, beds, medical exam tables, stools, and syringe destroyers. The company distributes medical devices and equipment through its manufacturing and distribution channels, targeting healthcare providers and hospitals. It also produces and trades diversified medicines, including antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal, and anti-allergic drugs, serving the broader healthcare market. The firm generates revenue from the sale of medical devices and equipment, as well as from pharmaceutical products. Healthcare providers and hospitals purchase the medical devices and equipment, while the diversified medicines are sold to pharmacies and healthcare institutions. Armephaco JSC's product portfolio includes glucose meters, sphygmomanometers, beds, medical exam tables, stools, syringe destroyers, antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal, and anti-allergic drugs. Armephaco JSC's business model centers on the production and distribution of medical devices and pharmaceuticals. The company's primary customers are healthcare providers, hospitals, pharmacies, and healthcare institutions. The revenue streams are derived from the direct sale of medical equipment and pharmaceutical products to these segments, with no mention of additional services or partnerships. Armephaco JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Armephaco JSC stock

Accounts Payable of Armephaco JSC is 417.96 B VND in 2025.

Accounts Payable of Armephaco JSC changed from 301.73 B VND to 417.96 B VND, representing a 38.52% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Payable Armephaco JSC since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's Armephaco JSC historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Armephaco JSC

All Key Metrics — Armephaco JSC